Wednesday, February 21, 2018

Indonesia Hospital Market is expected to Reach USD 14 Billion by 2022: Ken Research

Indonesia hospital market segment (by public & private hospitals, by general & specialty hospitals and by region), competitive landscape of major players in the Indonesia hospital market, and covering competitive landscape of major hospitals including Mitra Keluarga Karyasehat Tbk Pt, Siloam Hospitals, PT Sejahteraraya Anugrahjaya, Sarana Meditama, Rumah Sakit Pondok Indah, Surya Husadha General Hospital, Jakarta Eye Center, Rumah Sakit Dr Oen Surakarta, Pertamedika (Rumah Sakit Pusat Pertamina), Kaish Ibu Hospital, Hermina Hospital Group, Awal Bros Hospital Group and Sari Asih. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.
Increase in private hospitals has contributed significantly in the growth of hospital market. High quality of healthcare and less waiting time are the factors contributing to the growth of private hospitals beds.
Siloam Hospitals has the largest hospital network in the country. Public sector hospital has the larger share in terms of number of hospitals in 2017.
Indonesia is expected to observe 1.5 beds per 1,000 people by 2019 with the entry of several private hospital and increase in the capacity of number of beds in the existing ones.
Single specialty or multi-specialty hospitals in the country are planning to invest in advanced medical devices to provide tertiary or super specialty treatment to the patients. For instance, Mandaya Hospital expects to see sharp revenue growth i.e. 30.0% y-o-y rise in 2018 as the hospital will invest in new equipment that should boost demand. The hospital market is expected to rise owing to the government support in the industry. Before 2017 foreigners were only allowed to invest in specialist hospital and, not in general hospitals. However, after the government (through Presidential Regulation No. 44/2016) allowed foreigners to have a maximum stake of 67.0% in general hospitals (for ASEAN investors the maximum figure is 70.0%) FDI has started to rise rapidly. Foreign investments rose from USD 0.2 million in the year 2015 to USD 0.8 million in the year 2016. The foreign investment further increased to USD 14.3 million in the first half of 2017. The market expects higher growth potential in Tier I and Tier II cities due to larger demand supply gap and lower land acquisition cost.
Rising focus on high revenue intensity streams which includes secondary care, tertiary care and quaternary care and comprehensive health screening programs to increase contribution from outpatients coupled with elevating prevalence of chronic and lifestyle diseases will propel the Indonesia hospital market revenue in future. One of the important issues for the hospital market in Indonesia is the lack of qualified physicians and nurses in the hospitals located in the rural areas due to low standard of nursing education in the country.
Ken Research in its latest study, “Indonesia Hospital Market Outlook to 2022 - By Public & Private Hospital, By General & Specialty Hospital, By Region”, suggests that demand for healthcare services in the market will continue to grow in Indonesia owing to favorable government regulations for FDI inflows and rising prominence of health tech startups.
Key Topics Covered in the Report:
Indonesia Hospital Market Size
Indonesia Hospital Market Research
Indonesia Private Hospital Market
Hospitals in Jakarta Area
Number of Public Hospitals Indonesia
Number of Private Hospitals Indonesia
Investment in Hospital Indonesia
For more information on the research report, refer to below link:
Related Reports by Ken Research
Contact:         
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Global Lupus Nephritis Clinical Trials Market Outlook to 2017: Ken Research

GlobalData'sclinical trial report, Lupus Nephritis Global Clinical Trials Review, H2, 2017" provides an overview of Lupus Nephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Nephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months

Key Topics Covered in the Report:
Global Lupus Nephritis Clinical Trials Market Outlook
Global Lupus Nephritis Clinical Trials Market Size
Global Lupus Nephritis Clinical Trials Market Trends
Global Lupus Nephritis Clinical Trials Market Demand
Global Lupus Nephritis Clinical Trials Market Volume
Global Lupus Nephritis Clinical Trials Market Analysis
Global Lupus Nephritis Clinical Trials Market Forecast
Europe Lupus Nephritis Clinical Trials Market Industry Research
US Lupus Nephritis Clinical Trials Market Revenue
Global Lupus Nephritis Clinical Trials Market Share

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Global Lupus Erythematosus Clinical Trials Market Research Report to 2017: Ken Research

GlobalData'sclinical trial report, Lupus Erythematosus Global Clinical Trials Review, H2, 2017" provides an overview of Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years

Key Topics Covered in the Report:
Global Lupus Erythematosus Clinical Trials Market Research Report
Global Lupus Erythematosus Clinical Trials Market Size
Global Lupus Erythematosus Clinical Trials Market Trends
Global Lupus Erythematosus Clinical Trials Market Analysis
Global Lupus Erythematosus Clinical Trials Industry Research
Global Lupus Erythematosus Clinical Trials Market Revenue
Global Lupus Erythematosus Clinical Trials Market Forecast
Global Lupus Erythematosus Clinical Trials Market Volume
Global Lupus Erythematosus Clinical Trials Market Demand
Europe Lupus Erythematosus Clinical Trials Market

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Tuesday, February 20, 2018

Indonesia Hospital Market Future Outlook to 2022: Ken Research

The report titled “Indonesia Hospital Market Outlook to 2022 - By Public & Private Hospital, By General & Specialty Hospital, By Region” provides information on market size for Indonesia Healthcare and hospital. The report covers hospital market segment by public & private hospitals, by general & specialty hospitals and by region along with competitive landscape of major hospitals including Mitra Keluarga Karyasehat Tbk Pt, Siloam Hospitals, PT Sejahteraraya Anugrahjaya, Sarana Meditama, Rumah Sakit Pondok Indah, Surya Husadha General Hospital, Jakarta Eye Center, Rumah Sakit Dr Oen Surakarta, Pertamedika (Rumah Sakit Pusat Pertamina), Kaish Ibu Hospital, Hermina Hospital Group, Awal Bros Hospital Group and Sari Asih. The report concludes with market projections for future and analyst recommendations highlighting the major opportunities and cautions.
Indonesia Hospital Market Overview
The hospital market in Indonesia forms an important component of the overall healthcare market in Indonesia. Indonesia Hospital Market grew from USD ~ million in the year 2012 to USD ~ million in the year 2017. The number of public hospitals increased from ~ in 2012 to ~ in 2016 and the private hospitals increased from ~ in 2012 to ~ in 2016. The market has been facilitated by increasing prevalence of the severe chronic diseases in Indonesia. Several diseases such as Pneumonia, Multi-bacillary (MB) Leprosy and Diarrhea had increased in the year 2015. The coverage of pneumonia findings in under-fives increased to ~% in 2015 against ~% in the 2014, the proportion of people under MB Leprosy increased to ~% in 2015 against ~% in 2014. Further, the private firms have increased focus on high revenue intensity streams which includes secondary care, tertiary care and quaternary care and comprehensive health screening programs to increase contribution from outpatients.
Indonesia Hospital Market Segmentation
By Public and Private Hospitals: Public hospitals have accounted for ~% of the number of hospitals on account of the increase in the government budget allocation on healthcare. Private hospitals have registered ~% of the total hospitals in Indonesia in 2016 as the demand for modern medicine and specialist services increased in the country.
By General and Specialty Hospitals: General hospitals have accounted for ~% of the total number of hospitals whereas specialty hospitals which include hospitals such as mental hospital, leprosy hospital, eye hospital and others have registered ~% of the total number of hospitals.
By Type of Specialty Hospitals: Mother and children has accounted for ~% of the number of specialty hospitals in 2015 followed by maternity hospitals with ~% and mental hospital with ~% of the share in 2015. Rest of the market includes Eye hospital, leprosy hospital and pulmonary tuberculosis hospital with ~%, ~% and ~% respectively of the total number of specialty hospitals in 2015. Other specialized hospitals have registered ~% of the market share in 2015.
By Region: East Java has gathered ~% of the number of beds in Indonesia in 2016 owning to the high number of disaster in the region followed by Central Java with ~%, West Java with ~%, Jakarta with ~%, North Sumatra with ~%, South Sulawesi with ~%. On the other hand, underdeveloped regions such as North Kalimantan, West Sulawesi and North Maluku have accounted for ~%, ~% and ~% of the number of hospital beds in 2016 respectively.
Indonesia Hospital Market Competition Overview
There are ~ hospitals in Indonesia in 2016 of which ~% are public hospitals and ~% are private hospitals. There are ~ major private hospitals in Indonesia operated by top 10 private participants in 2015. Long waiting queues at public hospitals, quality of service and need for specialist doctors will drive Out-of-pocket patients to these private hospitals by 2019. Major hospitals include Siloam Hospital group, Hermina Hospital Group, Rumah Sakit Mitra, Awal Bros Hospital Group, Sari Asih Group, Ramsay Sime Darby Healthcare and Eka Hospital group. Major competition parameters for private hospitals are facilities, number of beds, number of hospitals, fees, quality of doctors/medical practitioners and specialization.
Indonesia Hospital Market Future Potential
The hospitals market in Indonesia is expected to grow at a five year CAGR of ~% during 2017-2022. The hospital market is expected to rise owing to the government support in the industry which will encourage foreign investment in the sector. More than 35,000 new beds are likely to be added in Indonesia by 2020. Moreover, due to the entry of new participants into the private hospital market and expansion of existing ones, the country is expected to achieve ~ beds per 1,000 people by 2019. The number of hospitals is expected to increase to ~ in 2022 in which ~ are expected to be private and ~ are expected to be public.
Key Topics Covered in the Report:
Hospitals in Jakarta Area
Jakarta Hospital Market
Indonesia Hospital Revenue
Inpatient Revenue Indonesia
Outpatient Revenue Indonesia
Number of Inpatients Indonesia
Number Outpatients Indonesia
Indonesia Private Hospital Market
Hospitals and Clinics Market Indonesia
Hospital Market Indonesia
Siloam Hospital Competitor Indonesia
Hospital Market Trends Indonesia
Number of Public Hospitals Indonesia
Number of Private Hospitals Indonesia
Trends Indonesia Hospital Industry
Challenges Indonesia Hospital Market
Major Hospital Projects in Indonesia
Regulations Indonesia Hospital market
Indonesia Number of General Hospitals
Number of Specialty Hospitals Indonesia
Type of Specialty Hospitals Indonesia
Major Companies Hospitals Market Indonesia
Business Model Indonesia Hospital
Hospital Spending Indonesia
Revenue Streams Hospitals Indonesia
Investment in Hospital Indonesia
Super Specialty Hospital Market Indonesia
General Hospital Valuation Indonesia
Acquisitions Hospital Indonesia
Funding Hospital Indonesia
For more information on the research report, refer to below link:
Related Reports by Ken Research
Contact:         
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Monday, February 19, 2018

Indonesia Pharmaceutical Market is expected to Reach USD 10.3 Billion by 2022: Ken Research

Indonesia pharmaceutical market segment (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region), competitive landscape of major players in the Indonesia pharmaceutical market covering company profile of PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT Dexa Medica, PT Pharos, PT Kimia Farma, PT Tempo Scan Pacific Tbk, PT Merck Tbk, Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.
Majority pharmaceutical companies are located in West Java and Jakarta due to favorable tax incentives, well developed infrastructure and greater access to medicinal herbs.
Healthcare industry in Indonesia is driven by the surging number of hospitals, clinics and pharmacy stores coupled with rising prevalence of chronic diseases including diabetes, HIV, Tuberculosis and others. It is anticipated that over 35,000 new beds will be added in Indonesia by 2020. Indonesia is anticipated to achieve 1.5 beds per 1,000 people by 2019 with the entry of new private hospitals and increased capacity of existing ones.
Indonesia Pharmaceutical Market Research Report
The pharmaceutical sector will observe a rise in demand for nutrition and vitamin and dietary supplements. Pharmaceutical companies are anticipated to shift focus to other niche segments including combined dosages, novel drug delivery areas besides manufacturing generic and patented drugs. Indonesia pharmaceutical market is anticipated to grow in future with surging ageing population, increased health care spending and rise in lifestyle related diseases.
The distribution channel will be dominated by hospital and clinics which implies a shift from physicians and pharmacies. So the companies now need to target the hospitals and clinics more in their marketing activities. The industry will witness an increased investment from foreign players and the prevalence of chronic diseases such as cancer, HIV and others will lead to increase demand for innovative products particularly in the field of biopharmaceuticals. With the increase in role of government in the Indonesian healthcare industry, the pharmaceutical companies need to look for government tenders as government opts for e-procurement methods to procure medicines for various public and private hospitals participating in the universal healthcare system
Emerging Contract Development and Manufacturing Organizations market, increasing number of mergers & acquisitions coupled with elevating prevalence of chronic and lifestyle diseases will propel the Indonesia pharmaceutical market revenue in future.
Ken Research in its latest study, “Indonesia Pharmaceutical Market Outlook to 2022 – By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology), By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region”, suggests that demand for pharmaceutical products in the market will continue to grow in Indonesia owing to favorable government regulations for FDI inflows and growing vitamin and dietary supplements market.
Key Topics Covered in the Report:
Pharmaceutical Market Size Indonesia
Kalbe Farma Competitors Indonesia
Healthcare Spending Indonesia
Obese Population Indonesia
Indonesia Healthcare Market Future
Animal Pharmaceutical Market Indonesia
Biopharmaceutical Market Indonesia
Indonesia Vaccine Market
Generic Drug Market Size Indonesia
Market Share of Major Players in Indonesia Pharmaceutical Market
Vitamin and Dietary Supplement Market Indonesia
Major Therapeutic Segment in Indonesia Pharmaceutical Market
Type of Generic Drugs in Indonesia
Mergers & Acquisitions in Indonesia Pharmaceutical Market
Pharmaceutical Market Exports Indonesia
Pharmaceutical Market Future Trends Indonesia
Number of Pharmaceutical Companies Indonesia
Trends Indonesia Pharmaceutical Market
Issues & Challenges in Indonesia Pharmaceutical Market
Government Regulations in Indonesia Pharmaceutical Market
Number of Healthcare Centers in Indonesia
Budget Allocation on Healthcare Indonesia
Major Companies Pharmaceutical Market Indonesia
For more information on the research report, refer to below link:
Related Reports by Ken Research
Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204